NIH-funded research R01 grant

Mapping hidden brain cell changes in drug-resistant epilepsy

Official title: Deciphering brain mosaicism in drug-resistant epilepsy at cellular resolution

Funded at Research Inst Nationwide Children's Hosp · NIH-11263699 · Data updated 2026-11-12

This project looks for tiny genetic changes in brain cells of children with drug-resistant epilepsy caused by brain malformations to help guide better diagnosis and treatments.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionResearch Inst Nationwide Children's Hosp
NIH-funded
Lab location1 site (Columbus, United States)
Project startMarch 1, 2023
Project endDecember 31, 2027
Funding year2026
Award (this year)$544,016
NIH project number5R01NS129784-04
Project IDNIH-11263699 on NIH RePORTER

Who could benefit from this research

Could help

Children and young people with focal malformations of cortical development and drug-resistant seizures who are being evaluated for or undergoing epilepsy surgery are the most likely candidates.

Less likely to help

People with generalized epilepsy, seizures not caused by cortical malformations, or those who are not surgical candidates are less likely to benefit directly from this project.

What this research studies

If you join, doctors will analyze tissue from epilepsy surgery using very sensitive genetic methods to find rare mutations present only in some brain cells. They will use single-cell sequencing to identify which kinds of brain cells carry those mutations and how the mutations change gene activity. The team will then test those mutations in lab cell models that match the affected cell types to see how they affect cell function. This approach aims to link specific cell-level changes to seizure causes so future care can be more precise.

Why it matters

Potential benefit: If successful, this work could help diagnose hidden genetic causes of drug-resistant epilepsy and point toward more targeted treatments for affected patients.

How similar studies have gone: Previous studies have found somatic mutations in malformations of cortical development and single-cell methods are promising, but applying them to map cell-type-specific effects and perform functional validation is a relatively new approach.

Where this research is happening

  • Research Inst Nationwide Children's Hosp
    Columbus, United States
    Active

Researchers

  • Principal investigator: Bedrosian, Tracy Ann — Research Inst Nationwide Children's Hosp
  • Study coordinator: Bedrosian, Tracy Ann

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.